Kevin Fischbeck analyst BAML

Currently out of the existing stock ratings of Kevin Fischbeck, 37 are a SELL (15.29%), 130 are a BUY (53.72%), 75 are a HOLD (30.99%).

Kevin Fischbeck

Work Performance Price Targets & Ratings Chart

Analyst Kevin Fischbeck, currently employed at BAML, has had 69.54% of price targets met with an average potential upside of 24.65%, reached in 267 days on average.

Kevin Fischbeck has documented 472 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARDT, Ardent Health Partners.

Wall Street Analyst Kevin Fischbeck

Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS CORP).
The best stock recommendation documented was for HUM (HUMANA) on 6/24/2026. The price target of $380 was fulfilled within 2 days with a profit of $19.21 (5.32%), with a performance score of 26.62.

Average potential price target upside

AGL agilon health AMN AMN Healthcare Services APR Apria CCRN Cross Country Healthcare CI Cigna Corp CLOV Clover Health Investments Corp CNC Centene Corp CYH Community Health Systems DVA DaVita HealthCare Partners HCA HCA Holdings SEM Select Medical Holdings SGRY Surgery Partners THC Tenet Healthcare UHS Universal Health Services UNH UnitedHealth Group ALHC Alignment Healthcare LLC HUM Humana OSCR Oscar Health OSH Oak Street Health OPCH Option Care Health ELV Elevance Health MOH Molina Healthcare CSWC Capital Southwest EHC Encompass Health Corp MD Mednax AGTI Agiliti AHCO Adapthealth Corp ARDT Ardent Health Partners ACHC Acadia Healthcare Company AG First Majestic Silver Corp BHG Bright Health Group MGLN Magellan Health OS OneStream

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 09-May-2021

$170

$59.7 (54.13%)

$146

4 days ago
(12-Nov-2026)

Buy Since 19-Oct-2023

$145

$34.7 (31.46%)

$140

6 days ago
(10-Nov-2026)

4/11 (36.36%)

$30.19 (26.30%)

131

Hold Since 11-Jun-2023

$105

$-5.3 (-4.81%)

$125

12 days ago
(04-Nov-2026)

3/8 (37.5%)

$-8.77 (-7.71%)

7

Hold Since 16-Oct-2025

$125

$14.7 (13.33%)

$86

2 months 2 days ago
(14-Sep-2026)

5/9 (55.56%)

$32.88 (35.69%)

56

Sell Since 23-Aug-2026

$85

$-25.3 (-22.94%)

$150

2 months 24 days ago
(23-Aug-2026)

5/9 (55.56%)

$-8.79 (-9.37%)

25

Show more analysts

Please expand the browser size to see the chart

Which stock is Kevin Fischbeck most bullish on?

Potential upside of $67.54 has been obtained for UNH (UNITEDHEALTH GROUP)

Which stock is Kevin Fischbeck most reserved on?

Potential downside of -$70 has been obtained for HUM (HUMANA)

What Year was the first public recommendation made by Kevin Fischbeck?

On 2008
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?